HALO
Halozyme Therapeutics, Inc.
A San Diego biopharma company whose ENHANZE technology uses a naturally occurring enzyme to temporarily loosen the gel-like tissue under the skin, letting large-volume biologic medicines be injected in minutes instead of slowly dripped over hours. Its partners sell drugs built on this platform, such as DARZALEX FASPRO and HYQVIA, and it also makes auto-injector devices and its own products like XYOSTED. Co-founded in 1998 by Dr. Gregory Frost, the company's name blends "hyaluronidase" and "enzyme" — the very molecule its science revolves around.
CUSIP: 40637H109HealthcareUS4 holders
Total Value
$47.21M
Total Shares
603.1K
Net Share Change
-520.3K
Activity
1 buying2 selling
Investor
Value
Shares
Weight
Change
